Theravance Biopharma
TBPH
TBPH
135 hedge funds and large institutions have $512M invested in Theravance Biopharma in 2025 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 54 increasing their positions, 32 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
135
Holders Change
+4
Holders Change %
+3.05%
% of All Funds
1.81%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.07%
New
24
Increased
54
Reduced
32
Closed
20
Calls
$3K
Puts
$286K
Net Calls
-$283K
Net Calls Change
-$273K
Top Buyers
1 |
BlackRock
New York
|
$45.7M |
2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$5.55M |
3 |
JFG
Jefferies Financial Group
New York
|
$3.05M |
4 |
NM
Newtyn Management
New York
|
$54.6M |
5 |
Morgan Stanley
New York
|
$6.07M |